Newsroom

PARIS--(BUSINESS WIRE)--Havas reports the progress of transactions under its current share buyback program...

CHATOU, France--(BUSINESS WIRE)--Macnica ATD Europe today announced the acquisition of Indesmatech, a pan-European technology and advisory company specializing in advanced semiconductor representation, design-in support and consulting, as well as point click buying services. The acquisition is a strategic move by Macnica ATD Europe to strengthen its commercial and engineering presence across Scandinavia and Northern Europe, adding established regional relationships, in-house engineering capabil...

LONDON--(BUSINESS WIRE)--  TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Next 15 Group Plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer   2. Reason for the notification (please mark the appropria...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 11th May 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. NEW IMMO HOLDING Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 15 April 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 11th May 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Caisse des Dépôts et Consignations Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 21st April 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning...

LONDON--(BUSINESS WIRE)--  IMPORTANT NOTICE OF 2026 ANNUAL GENERAL MEETING OF XTRACKERS (IE) PLC (the Company) NOTICE is hereby given that the Annual General Meeting (the AGM) of the Company will be held at the offices of A&L Goodbody LLP, 25 North Wall Quay, Dublin 1, Ireland on 11 June 2026 at 09:30 am (Irish time) for the following purposes: To receive and consider the statutory financial statements for the year ended 31 December 2025 and the report of the directors on those statements a...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 11th May 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Louis Dreyfus Company Finance BV Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 14th April 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of...

INCHEON, Corea--(BUSINESS WIRE)--Samsung Epis Holdings (KRX: 0126Z0), una empresa de inversión dedicada a las innovaciones en el sector de la biofarmacéutica y biotecnología, anuncia sus resultados financieros correspondientes al primer trimestre del año fiscal 2026. “Samsung Bioepis ha registrado un sólido crecimiento este trimestre gracias al impulso constante de nuestra cartera de biosimilares”, declaró Kyung-Ah Kim, presidenta y directora ejecutiva (CEO) de Samsung Epis Holdings. “Estamos f...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection. The service will support researchers seeking to identify the most promising antibody candidates to progress to costly mammalian expression and functional testing, addressing a key bottleneck in AI-driven antibody discovery. The laun...

INCHEON, Corée--(BUSINESS WIRE)--Samsung Epis Holdings (KRX : 0126Z0), une société d’investissement dédiée à l’innovation dans les domaines de la biopharmacie et de la biotechnologie, a annoncé aujourd’hui ses résultats financiers pour le premier trimestre de l’exercice 2026. « Samsung Bioepis a enregistré une croissance solide ce trimestre, portée par la dynamique continue de notre portefeuille de biosimilaires », déclare Kyung-Ah Kim, présidente-directrice générale (CEO) de Samsung Epis Holdi...